A new technique for creating antibody-drug conjugates has already led to a startup company aimed at advancing the technology.
A new technique for creating antibody-drug conjugates has already led to a startup company aimed at advancing the technology.
Alum Apoorva Reddy leads new research revealing how CBD and THC differently influence sleep quality for people with cancer.
School of Pharmacy Assistant Professor Ting Fu and colleagues have identified a promising potential therapeutic lead for colorectal cancer.
PharmTox students are honored with Hilldale Fellowships, propelling their innovative research into Alzheimer’s and cancer.
Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring.
UW–Madison School of Pharmacy alumni and faculty share how they’ve been transforming patient outcomes, from opioids to heart failure and cancer care.
See the people, processes, and equipment behind Assistant Professor Cody Wenthur’s exploration into psychoactive substances.
With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancer.
With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer.